Vigilant Biosciences
  • Solutions
    • BeVigilant™ OraFusion System
  • Resources
    • Provider Resources
    • Patient Resources
  • About
    • Leadership
    • Careers
  • News
  • Contact
Select Page
Vigilant Biosciences Receives Breakthrough Device Designation from FDA for Point-of-Care Test to Aid in the Early Detection of Oral Cancer

Vigilant Biosciences Receives Breakthrough Device Designation from FDA for Point-of-Care Test to Aid in the Early Detection of Oral Cancer

by vigilantbio | Apr 27, 2023 | Press Release

LAKEWAY, Texas (April 27, 2023) — Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection of oral cancer, is proud to announce receipt of Breakthrough Device Designation from the Food and Drug...

Latest News

  • Challenges in the Early Detection of Oral CancerJune 7, 2023
  • When to Start Screening for Oral CancerMay 15, 2023
  • Vigilant Biosciences Receives Breakthrough Device Designation from FDA for Point-of-Care Test to Aid in the Early Detection of Oral CancerApril 27, 2023
  • Follow
  • Follow

Follow Us

Follow Us

  • Follow
  • Follow

Provider Resources

Patient Resources

About

Leadership

Careers

News

Contact

Vigilant Biosciences Logo, White

Privacy Policy | Terms of Use

© 2023 Vigilant Biosciences